Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

NCT07276880 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Triple Negative Breast Cancer (TNBC)
HER2-Negative Breast Carcinoma
Node-positive Breast Cancer

Interventions

DRUG: Neoadjuvant Pembrolizumab
RADIATION: low dose neoadjuvant boost
RADIATION: High dose neoadjuvant boost

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]